Professional Documents
Culture Documents
Definition:
An echocardiogram (often called "echo") is a graphic outline of the heart's movement . During an
echocardiogram test, ultrasound ( high-frequency sound waves) that comes from a hand-held wand placed on
your chest, is used to provide pictures of the heart's valves and chambers and help the sonographer evaluate the
pumping action of the heart. Echo is often combined with Doppler ultrasound and color Doppler to evaluate
blood flow across the hearts valves.
You can wear whatever you like to your appointment for echocardiogram. You will need to change into
a hospital gown to wear during echocardiography. Do not bring valuables.
You may eat and drink as you normally would on the day of the echocardiogram test.
Take all of your medications at the usual times, as prescribed by your doctor.
Before the echocardiogram test, a cardiac sonographer (an allied health professional who has been
trained specifically to perform ultrasound examinations), nurse or physician will explain the procedure
in detail, including possible complications and side effects. They will be available to answer any
questions you may have. You will be given a gown to wear for your echocardiography procedure. You
will be asked to remove your clothing from the waist up. A cardiac sonographer will place three
electrodes (small, flat, sticky patches) on your chest. The electrodes are attached to an
electrocardiograph monitor (ECG) that charts your hearts electrical activity.The sonographer will ask
you to lie on your left side on an exam table. The sonographer will place a wand (called a sound-wave
transducer) on several areas of your chest. The wand will have a small amount of cool gel on the end,
which will not harm your skin. This gel helps get clearer pictures. Sounds are part of the Doppler signal.
You may or may not hear the sounds during the test. You may be asked to change positions during the
exam in order to take pictures of different areas of your heart. You may be asked to hold your breath at
times. You should feel no major discomfort during the test. You may feel coolness from the gel on the
transducer and a slight pressure of the transducer on your chest.The echo test takes about 40 minutes.
After the echocardiogram test, you may get dressed and go home or go to your other scheduled
appointments.
After the cardiologist reviews your test, the results will go into your electronic medical record. Your
physician will have access to the results and will discuss them with you.
http://my.clevelandclinic.org/heart/services/tests/ultrasound/echo.aspx
What is a urinalysis?
A urinalysis is simply an analysis of the urine. It is a very common test that can be performed in many
healthcare settings including doctors' offices, urgent care facilities, laboratories, and hospitals.
It is performed by collecting a urine sample from the patient in a specimen cup. Usually only small amounts
(10-15 ml's) may be required for urinalysis testing.
Urinalysis can disclose evidence of diseases, even some that have not caused significant signs or symptoms.
Therefore, a urinalysis is commonly a part of routine health screening.
Urinalysis is also a very useful test that may be ordered by your physician for particular reasons. Urinalysis is
commonly used to diagnose a urinary tract or kidney infection, to evaluate causes of kidney failure, to screen
for progression of some chronic conditions such as diabetes mellitus and high blood pressure (hypertension).
It also may be used in combination with other tests to diagnose some diseases. Examples of this include kidney
stones, inflammation of the kidneys (glomerulonephritis), or muscle break breakdown (rhabdomyolysis).
Interpretation of urinalysis is generally based on reviewing all the components of the test as well as the clinical
symptoms and signs of the patient.
Urinalysis is done by collecting a urine sample from a patient. The optimal sample tends to be an early morning
urine sample because it is frequently the most concentrated urine produced in the day.
Methods of collection are slightly different for female and male patient.
For females, the patient is asked to clean the area around the urethra with a special cleansing wipe, by
spreading the labia of the external genitals and cleaning from front to back (toward the anus).
For men, the tip of the penis may be wiped with a cleansing pad prior to collection.
The urine is then collected in a clean urine specimen cup while the patient is urinating. It is best to avoid
collecting the initial stream of urine. After the initial part of urine is disposed of in the toilet, then the urine is
collected in the urine container provided. Once about 10-15 ml (roughly 3-4 tablespoons) are collected in the
container for testing, the remainder of the urine may be voided in the toilet again. This is called the clean catch
or the midstream urine collection.
The collected urine sample should be taken to the laboratory for analysis, typically within one hour of
collection. If transportation to the lab could take more than one hour, then the sample may be refrigerated.
In some patients who are unable to void spontaneously or those who are not able to follow instructions other
methods may be used, such as placing a catheter (a small rubber tube) through the outside opening to the
bladder (urethra) to collect the sample directly from the bladder.
Macroscopic urinalysis is the direct visual observation of the urine, noting its quantity, color, clarity or
cloudiness, etc.
Normal urine is typically light yellow and clear without any cloudiness. Obvious abnormalities in the color, clarity, and
cloudiness may suggest possibility of an infection, dehydration, blood in the urine (hematuria), liver disease, breakdown
of muscle or red blood cells in the body. Certain medications may also change the color of urine. Very foamy urine may
represent large amounts of protein in the urine (proteinuria).
Urine dipstick is a narrow plastic strip which has several squares of different colors attached to it. Each small
square represents a component of the test used to interpret urinalysis. The entire strip is dipped in the urine
sample and color changes in each square are noted. The color change takes place after several seconds to a few
minutes from dipping the strip. If read too early or too long after the strip is dipped, the results may not be
accurate.
The squares on the dipstick represent the following components in the urine:
glucose (sugar),
Presence or absence of each of these color changes on the strip provides important clues for your doctor to
make clinical decisions based on the urinalysis results.
The main advantage of dipsticks is that they are convenient, easy to interpret, and cost-effective for urinalysis
testing. They can be analyzed within minutes of urine collection in the doctor's office or in the emergency room
to provide valuable information.
However, what can be learned from a dipstick is limited by the design of the dipstick. The main disadvantage is
that the information may not be very accurate as the test is time-sensitive. It also provides limited information
about the urine as it is qualitative test and not a quantitative test (for example, it does not give a precise measure
of the quantity of abnormality).
The microscopic urinalysis is the study of the urine under the microscope. It requires only a relatively
inexpensive light microscope. Cells and cellular debris, bacteria, and crystals in the urine can detected by this
examination to provide further clinical clues.
Microscopic urinalysis is done simply pouring the urine sample into a test tube and centrifuging it (spinning it
down in a machine) for a few minutes. The top liquid part (the supernatant) is discarded. The solid part left in
the bottom of the test tube (the urine sediment) is mixed with the remaining drop of urine in the test tube and
one drop is analyzed under a microscope.
First, the sediment is examined through the microscope under low-power to identify what are called casts,
crystals, squamous (flat) cells, and other large objects.
Examination is then performed through the microscope at high power to further identify any cells, bacteria and
clumps of cells or debris called casts.
Epithelial (flat cells) and red and white blood cells may be seen in the urine.
Sometimes cells, cellular debris, and casts are seen in the microscopic urinalysis. Epithelial cells (cells in the
lining of the bladder or urethra) may suggest inflammation within the bladder, but they also may originate form
the skin and could be contamination.
Casts and cellular debris originate from higher up in the urinary tract, such as in the kidneys. These are material
shed from kidney cell lining and travel down through the urinary tubes. These usually suggest an injury to the
kidney from an inflammation or lack of blood flow to the kidneys. Rarely, tumor cells can be in the urine
suggesting a urinary tract cancer.
What can the presence of red blood cells in the urine mean?
Red blood cells can enter the urine from the vagina in menstruation or from the trauma of bladder catherization.
A high count of red blood cells in the urine can indicate infection, trauma, tumors, kidney stones. If red blood
cells seen under microscopy look distorted, they suggest kidney as the possible source and may arise due to
kidney inflammation (glomerulonephritis). Small amounts of red blood cells in the urine are sometimes seen
young healthy people and not indicative of any disease.
What can the presence of white blood cells in the urine mean?
Urine is a generally thought of as a sterile body fluid, therefore, evidence of white blood cells or bacteria in the
urine is considered abnormal and may suggest a urinary tract infection such as, bladder infection (cystitis),
infection of kidney (pyelonephritis). White blood cells may be detected in the urine through a microscopic
examination (pyuria or leukocytes in the blood). They can be seen under high power field and the number of
cells are recorded (quantitative).
White cells from the vagina or the opening of the urethra (in males, too) can contaminate a urine sample. Such
contamination aside, the presence of abnormal numbers of white blood cells in the urine is significant.
http://www.medicinenet.com/urinalysis/article.htm
Hematology, also spelled haematology (from the Greek haima "blood" and -o), is the branch of
internal medicine, physiology, pathology, clinical laboratory work, and pediatrics that is concerned with the
study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology,
diagnosis, treatment, prognosis, and prevention of blood diseases. The laboratology work that goes into the
study of blood is frequently performed by a medical technologist. Hematologists physicians also very frequently
do further study in oncology - the medical treatment of cancer.
Blood diseases affect the production of blood and its components, such as blood cells, hemoglobin, blood
proteins, the mechanism of coagulation, etc.
Physicians specialized in hematology are known as hematologists. Their routine work mainly includes the care
and treatment of patients with hematological diseases, although some may also work at the hematology
laboratory viewing blood films and bone marrow slides under the microscope, interpreting various
hematological test results. In some institutions, hematologists also manage the hematology laboratory.
Physicians who work in hematology laboratories, and most commonly manage them, are pathologists
specialized in the diagnosis of hematological diseases, referred to as hematopathologists. Hematologists and
hematopathologists generally work in conjunction to formulate a diagnosis and deliver the most appropriate
therapy if needed. Hematology is a distinct subspecialty of internal medicine, separate from but overlapping
with the subspecialty of medical oncology. Hematologists may specialize further or have special interests, for
example in:
only some blood disorders can be cured. Hematology as basic medical science
Blood
o Venous blood
o Venipuncture
o Hematopoiesis
o Blood tests
o Cord blood
Red blood cells
o Erythropoiesis
o Erythropoietin
o Iron metabolism
o Hemoglobin
o Glycolysis
o Pentose phosphate pathway
Reticuloendothelial system
o Bone marrow
o Spleen
o Liver
Lymphatic system
Blood transfusion
o Blood plasma
o Blood bank
o Blood donors
o Blood groups
Hemostasis
o Coagulation
o Vitamin K
Complement system
o Immunoglobulins
Treatments
Treatments include:
Diet advice
Oral medication - tablets or liquid medicines
Anticoagulation therapy
Intramuscular injections (for example, Vitamin B12 injections)
Blood transfusion (for anemia)
Venesection also known as therepeutic phlebotomy (for iron overload or polycythemia)
Bone marrow transplant (for example, for leukemia)
All kinds of anti-cancer chemotherapy
Radiotherapy (for example, for cancer)
http://en.wikipedia.org/wiki/Hematology
Abstract
Rheumatic fever is an immunologically mediated inflammatory disease, that occurs as a delayed sequel to group
A streptococcal throat infection, in genetically susceptible individuals. Chronic rheumatic heart disease remains
an important public health problem in developing countries. Aetiopathogenesis and guidelines for the diagnosis,
prevention and treatment of acute rheumatic fever are reviewed.
Article
Introduction
Rheumatic fever (RF) is a multisystem, immunologically mediated inflammatory disease, that occurs as a
delayed sequel to group A streptococcal (GAS) infection. Its subsequent complication, chronic rheumatic heart
disease (RHD), remains a major public health problem in developing countries.
Epidemiology
The epidemiology of RF in developed countries has changed dramatically over the past decades. In developing
areas, the prevalence is still high at up to 24 per 1000 population.1 Rheumatic fever occurs most frequently
among children and adolescents between 5 and 18 years,2 coinciding with the age distribution of the highest
prevalence of streptococcal infections.
Aetiopathogenesis
The pathogenic mechanisms involved in the development of RF remain unclear. However, it is evident that an
abnormal humoral and cellular immune response occurs. Antigenic mimicry between streptococcal antigens,
mainly M-protein epitopes and human tissues, such as heart valves, myosin and tropomyosin, brain proteins,
synovial tissue and cartilage has been proposed as the triggering factor leading to autoimmunity in individuals
with genetic predisposition. 3 Several genetic markers of susceptibility have been studied but no consistent
association found.4 However, associations with different HLA class II antigens have been observed in several
populations.5-13 Molecular mimicry was first demonstrated by humoral immune response. Streptococcal
antibodies cross-react with several human tissues including heart, skin, brain, glomerular basement membrane,
striated and smooth muscles.14 The presence of CD4+ T cells at lesions sites in the heart has been demonstrated,
suggesting a direct role of these cells in the pathogenesis of RHD.15,16 Infiltrating T lymphocytes from heart
lesions of severe RHD patients and peripheral T lynphocytes were capable of recognising immunodominant
myocardium M5 peptides and valve proteins. These results showed the significance of molecular mimicry
between beta hemolytic streptococci and heart tissue assessing the T-cell repertoire leading to local tissue
damage in RHD.17,18 Figure 1 illustrates the events that occur during the development of RF/RHD.
Figure 1: Schematic representation of the aetiopathogenic events occurring during the development of
carditis
Major Clinical Manifestations
Arthritis
Arthritis is the most common manifestation, present in 60-80% of patients. 19,20 Itu sually affects the peripheral
large joints; small joints and axial skeleton are rarely involved. Knees, ankles, elbows and wrists are the most
frequently affected. In addition to arthralgia, the joints are red, warm and swollen. Arthritis is characteristically
asymmetrical, migratory, and very painful, although some patients may present mild joint complaints. It usually
resolves spontaneously at the most in 2 or 3 weeks. Arthritis in ARF has an excellent response to salicylates.21
Approximately one third of patients with joint involvement reported in a series of 786 cases of RF presented
with "atypical" articular manifestations, considered by some as a separate entity, i.e., post-streptococcal reactive
arthritis. It seems reasonable to include these manifestations as part of the spectrum of RF.19,21 Secondary
prophylaxis should be recommended in these situations.
Carditis
Acute carditis was present in 50% of patients in a large recent series. 19 It is a pancarditis, but valvular
involvement is the rule. The commonest involved valve is the mitral, frequently associated with aortic valve
involvement. Right-sided heart valves are rarely affected.
On pathological examination, the valves are thickened and display rows of small vegetations along their
apposing surfaces (Figure 2). Myocarditis is characterised by infiltration of mononuclear cells, vasculitis and
degenerative changes of the interstitial connective tissue.22 The pathognomonic lesion is the Aschoff body in the
proliferative stage, present in 30 to 40 per cent of biopsies of patients with acute RF.23 It is seen mainly in the
interstitial connective tissue of the myocardium, particularly perivascularly (Figure 3).22 Inflammation of the
valves consists of oedema and mononuclear cell infiltration of the valvular tissue and the chordae tendineae in
the acute phase; fibrosis and calcification occur with maintenance of the inflammatory process.22
Figure 2: Aortic valve showing active valvulitis. The valve is slightly thickened and displays small
vegetations "verrucae"
Figure 3: Myocardial Aschoff body the cells are large, elongated, with large nuclei; some are
multinucleate
The clinical picture includes high pulse rate, congestive heart failure, arrhytmias and pericardial friction rubs.
On the first attack, valvulitis is suspected in the presence of a new apical systolic murmur of mitral regurgitation
(associated or not with an apical mid-diastolic murmur) and/or a basal diastolic murmur of aortic
regurgitation.24 Cardiomegaly is noted on X-Ray (Figure 4) and on echocardiogram. Myocarditis and/or
pericarditis in the absence of valvular involvement is unlikely due to acute RF.24 It is contentious if myocardial
disfunction in acute RF is valvular or myocardial in origin.25 In fact, in a subset of patients, the initial
presentation may be quite severe, with overt heart failure, fever and toxaemia, making the differential diagnosis
with infective endocarditis very difficult, in particular in patients with recurrent rheumatic heart disease.
Figure 4 : Chest radiograph of an 8 year old patient with acute carditis before treatment
Figure 7: Two-
dimensional parasternal
long-axis view of a patient
with mitral stenosis,
showing thickened valve
cusps (arrow), with poor
leaflet separation in
diastole. Left atrium is
enlarged, with a
thrombus in the posterior
aspect of it. Aortic valve
is also stenotic
Figure 8: Stenotic mitral
valve seen from left
atrium. Both
commissures are fused;
the cusps are severely
thickened. The left
atrium is huge. The valve
is both incompetent and
stenotic
Sydenhams chorea
Sydenhams chorea is characterized by involuntary movements, specially of the face and limbs, muscle
weakness, disturbances of speech and gait. Children usually exhibit concomitant psycologic dysfunction,
especially obsessive-compulsive disorder, increased emotional lability, hyperactivity, irritablility and age-
regressed behavior.26-28 It is usually a delayed manifestation, and is often the sole manifestation of ARF.
However, chorea may occur in association with other major manifestations of RF, particularly in the first
attack.29 Evidence of a recent GAS infection is often difficult to document. Most of the patients experience
resolution of the symptomatology after a few months.3,24 However, a recurrence rate up to 32% has been
described, despite the regular use of secondary benzathine penicillin prophylaxis. Some believe that these
episodes represent exacerbations rather than distinct attacks of acute RF.29,30
Subcutaneous nodules
Diagnosis
With the exception of Sydenhams chorea, which has a latency period of several months, the clinical
manifestations of acute RF present after about 3 weeks following the streptococcal throat infection. It usually
begins with nonspecific symptoms, such as fever, malaise and persistent pallor.3
There is no specific clinical or laboratory test that establishes the diagnosis of RF. Diagnosis is based on the
revised Jones Criteria24 (Table 1). Arthritis, carditis, chorea, and less frequently, subcutaneous nodules and
erythema marginatum are major manifestations of RF. If supported by evidence of preceding streptococcal
infection, the presence of two major manifestations or one major and two minor manifestations indicates a high
probability of acute RF. The two exceptions to this requirement are Sydenhams chorea and indolent carditis.
Other manifestations include arthralgia, serositis and involvement of the kidneys and lungs.3
Table 1: Guidelines for the diagnosis of initial attack of rheumatic fever (Jones Criteria, 1992 Update).24
Major manifestations Minor manifestations
Carditis Fever
Polyarthritis Arthralgia
Sydenhams chorea Elevated acute phase reactants
Erythema marginatum Prolonged PR interval
Subcutaneous nodules
* plus supporting evidence of preceding GAS infection
Differential diagnosis
The differential diagnosis is extensive because of the lack of specificity of many of the clinical and laboratory
findings in RF and also the unavailability of a laboratory test to confirm the diagnosis. Several diseases need to
be considered. Table 2 includes those more often presenting clinical difficulties to the clinician. Juvenile
rheumatoid arthritis (JRA) and other connective tissue diseases often should be considered. The articular
involvement in JRA usually lasts longer than in RF. It is generally polyarticular and symmetrical, typically
affecting the small joints of the hands. Patients complain of increased pain in the morning or after long periods
of immobility. Arthritis of the cervical spine occurs in about half of the cases but is also quite frequent in acute
RF.3
Cardiac involvement presents primarily as pericarditis therefore infective endocarditis should be considered in
patients with recurrent RF presenting with persistent fever of unknown origin. Sometimes the differential
diagnosis can be difficult, especially in those presenting with a more severe clinical presentation.
Splenomegaly, vascular and immmunologic phenomena, demonstration of vegetations on echocardiogram and
positive blood cultures are indicative of infective endocarditis. Gallium-67 cardiac scintigraphy can be helpful
in this setting.
Systemic lupus erythematosus (SLE) shares clinical characteristics with acute RF. Arthralgia and transient
arthritis are common. SLE affects multiple organs, including kidney, central nervous system, skin, and blood.
Diagnosis is made on clinical grounds and confirmed by serologic studies.32
Laboratory studies
Acute phase reactants are useful in helping to recognize acute RF and also to exclude other diseases. C-reactive
protein and erythrocyte sedimentation rates are helpful in monitoring inflammatory activity.24
Laboratory evidence of a preceding GAS infection should be sought, either by demonstration of GAS in the
throat by culture or rapid streptoccocal antigen test, or using streptococcal antibody tests. Elevated or rising
titers of antistreptolysin O (ASO) occur in more than 80% of patients with acute GAS pharyngitis.24 There is a
remarkable response during the acute phase of RF. The test specificity has been shown to be 93% with ASO
titers above 960 IU/ml.33
Prolonged P-R interval relative to heart rate is a nonspecific finding, present in more than one third of the
patients. Low-voltage QRS complexes and ST segment changes may be found in the presence of pericarditis
and pericardial effusion.3
Endomyocardial biopsy is invasive and does not appear to provide additional diagnostic information where
there is a clinical consensus about the diagnosis of RF, with a diagnostic sensitivity in one relatively large study
of 27%. It should be limited to clinical investigation.23,34
Cardiac scanning scintigraphy has been shown to be a reliable method distinguishing acute from chronic,
inactive RHD and also in the follow-up of active carditis (Figure 13). 35-37
The role of echocadiography to diagnose valvulitis without auscultatory findings has been debated.34,38-41 At
present, subauscultatory valve regurgitation is not considered a diagnostic criterion for RF.24
Treatment
Prevention
Prevention of initial attacks of RF (primary prevention) requires the eradication of GAS from the pharynx.
Table 3 shows the currently recommended treatment schedules.42 Emphasis should be given to the need of
eradication of GAS as part of the treatment of acute RF.
Estolate or
(maximum 1g/d)
The following are unsuitable: sulfonamides, trimetroprim, tetracyclines and chloranphenicol.
Antibiotic prophylaxis is the safest way to prevent recurrent attacks of acute RF and is recommended for
patients with well-documented RF. The recommendations from the Committee on Rheumatic Fever,
Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American
Heart Association are shown on Table 4.42
penicillin G or
Penicillin V 250mg twice daily, PO
or
Sulfadiazine 500mg once daily for patients < 27kg; 1g once daily for patients
> 27kg, PO
For individuals allergic to penicillin and sulfadiazine:
Erythromycin 250mg twice daily, PO
*In high-risk situations, administration every 3 weeks is recommended.
Arthritis
Salicylates remain the first-line drugs in the treatment of arthritis. The response is usually excellent. Treatment
should be started at 80 to 100 mg/kg/day (maximum, 4g daily) for 3-4 weeks. Naproxen (10-15mg/kg/day, bid)
is an alternative drug, with very good response. Other nonsteroidal antiinflammatory drugs also can be used.
Carditis
Moderate to severe carditis is usually an indication for cortiscoteroids although efficacy in reducing sequelae
has not been proven so far. Albert at al. performed a meta-analysis of the literature on the treatment of
rheumatic carditis, comparing corticosteroids and salicylates in preventing valvular damage. It seems clear that
corticosteroids are superior to salicylates in rapidly resolving acute manifestations, but the advantage of the
former in preventing a pathologic murmur at 1 year posttreatment was not statistically significant. 43 Prednisone,
2mg/kg/day (maximum, 60mg/day) is used for two weeks and after that, the dose is gradually tapered, reducing
20 to 25% of the previous dose every week. Some advocate the concomitant use of salicylates to avoid rebound.
In severe carditis, therapy may be initiated with intravenous methylprednisolone.44,45 Intravenous
immunoglobulin seems not to alter the extent and severity of carditis or decrease chronic morbitidy. 46
Heart failure usually responds to steroids. Bed rest is always recommended and should be planned on an
individual basis. Diuretics and vasodilators may be used in patients with more severe haemodynamic
decompensation. Digoxin should be used with caution because of the risk of toxicity in the presence of active
myocarditis.47 Surgical treatment in the acute stage should be considered when clinical therapy is ineffective to
control cardic failure. Valve repair, although technically more difficult, is the first choice for younger patients.48
Chorea
Treatment with haloperidol (initial dose of 0.5 to 1mg/kg/day, maximum, 5mg/day) 49 or valproic acid (15-20
mg/kg/day)50 51are helpful in decreasing the severity of involuntary movements but may not improve the
behavioral symptoms. Carbamazepine has also been suggested as a first-line treatment for Sydenhams
chorea.52 Alternatively, phenobarbital also may be used, 5-7mg/kg/day, tid. Treatment is usually maintained for
8-12 weeks. Intravenous immunoglobulin therapy has been suggested.26
http://www.health.gov.mt/impaedcard/issue/issue11/1231/1231.htm